https://www.selleckchem.com/products/blu-945.html
ses differential diagnoses and monitoring disease activity, but further studies on larger groups of patients are necessary. We conclude that there is a different profile of blood-brain-barrier disruption reflected by cell adhesion molecules shedding in the spectrum of autoimmune CNS disorders with disseminated white matter lesions. These molecules could become new biomarkers to be used in CNS demyelinating diseases differential diagnoses and monitoring disease activity, but further studies on larger groups of patients are necessary. To
Мне нравится
Комментарий
Перепост
